AHC & ATP1A3 10 Year Conference & Symposium: PROFESSIONALS' TICKETS

Alternating Hemiplegia of Childhood UK (AHCUK)

10 years since the ATP1A3 gene discovery, this hybrid event highlights the progress to date and future research for AHC and ATP1A3 diseases

Royal College of Physicians of Edinburgh

This link is for bookings for Professionals ONLY(family bookings will be distributed separately in June via patient organisations. If you have not received this please contact support@ahcuk.org) PLEASE NOTE THAT THIS BOOKING IS AFTER THE DEADLINE FOR THE TEST PRACTICE OF THE ONLINE SYSTEM 'WEBEX'. The conference centre is unable to do further 'tests' in advance of the conference. We do provide a link to a document on how to follow joining Webex, but as the deadline has passed for the Webex check they may not be able to help with difficulties if you are unable to access the online system. This ticket is booked with this knowledge that the dates of the 'test' of the software has now passed. The full programme is now available online: https://www.ahcuk.org/conference-programme/This is a HYBRID EVENT - please select the correct ticket for the Venue (Face-to-Face) or Online----------------------‘DEFINING THE FUTURE FOR AHC &amp; ATP1A3 DISEASES’------------------------A 3 DAY UNIQUE EVENT INCORPORATING:•	10-year anniversary conference commemorating the discovery of the ATP1A3 gene in AHC and ATP1A3 diseases •	The 10th Symposium on ATP1A3 in disease This 3 Day unique event will be focused on those most impacted by research outcomes; with an opportunity to learn from their experiences and their priorities for future research to improve the research landscape and clinical care.It will also include an overview of the last 10 years since the gene discovery, alongside current and future research plans for AHC and ATP1A3 Diseases.-----------------------------Where? – Hybrid event - EDINBURGH and ONLINEFace-toFace VENUE: Conference Centre, The Royal College of Physicians of Edinburgh, 9 Queens Street, Edinburgh, EH2 1JQ When? - 19th-21st October 2022The conference will run from Wednesday-Friday (programme to be released shortly), with an evening formal dinner for delegates and speakers on Thursday 20th October (Great Hall, The Royal College of Physicians of Edinburgh) --------------------BRINGING TOGETHER PEOPLE WITH LIVED EXPERIENCE OFAHC AND ATP1A3 DISEASES, RESEARCHERS AND CLINICIANS-------------------To submit an oral or poster presentation, please email: support@ahcuk.org by 31st August 2022. All submissions must use accessible language and style. Prizes for best oral and poster presentation. --------------------The co-applicants and organising committee of the 10-year conference and 10th Symposium on ATP1A3 in disease are grateful for the generous grant from the European Joint Programme on Rare Diseases to support this event. ---------------

The Past, Present, FutureThe past 10 years, the present knowledge and defining the future priorities for Alternating Hemiplegia of Childhood (AHC) and ATP1A3 diseasesThis unique event will be a journey of discovery in Alternating Hemiplegia of Childhood (AHC) and ATP1A3 diseases since the gene discovery 10 years ago………Where have we come from, where have we reached, and what is next?It will incorporate the 10-year anniversary conference of AHC &amp; ATP1A3 diseases and the 10th Symposium on ATP1A3 in disease.Sessions will cover:•	AHC and ATP1A3 diseases – where are we now and where are we going?•	Collaborative science – the ATP1A3 community and what it has brought•	Sharing current research on AHC and ATP1A3 diseases: the life-course clinical perspective •	Key dilemmas for clinicians, researchers, and families•	Back to the lab – the latest updates on AHC &amp; ATP1A3 diseases advances in research•	Driving forward research and understanding in rare diseases: how can patients and families be involved in research?•	Driving forward knowledge in AHC and ATP1A3 diseases: how can learning from patients and families improve clinical care?•	Moving forwards with research: clinical trials•	Moving forwards with research: gene therapy strategiesMore information on all the sessions will be released in the coming weeks with the full programme Keynote plenary speaker In recognition of the 10- year anniversary since the ATP1A3 gene discovery for AHC and ATP1A3 diseases, we are delighted to announce:Professor Kathleen Sweadner'ATP1A3 disease –phenotypic description to gene discovery’Plenary talk discussing the basic science perspective of the gene discovery

The full programme, speakers and all presentations will be released shortly Here is a taster, including presentations and discussion on (more topics and information to follow):<ul><li>Future research priorities for families (and those with the lived experience of the diseases) and researchers/clinicians</li><li>Addressing the genotype-phenotype correlation in AHC and ATP1A3 diseases</li></ul><ul><li>ATP1A3 mutations cause polymicrogyria</li><li>Transition from childhood to adulthood</li><li>AHC – a lifelong disease. Long term follow-up of adults with AHC</li><li>Sleep issues in AHC and ATP1A3 diseases </li><li>Updates from TREAT AHC research study– What drugs are being tried?</li><li>ATP1A3 expression: spinal cord/motor function</li><li>Patient-driven registries</li></ul><ul><li>How to engage patients for faster transfer of research results to clinical practice</li><li>Preparing for clinical trials in AHC and ATP1A3 diseases</li><li>Updates in gene therapy research for AHC &amp; ATP1A3 diseases </li></ul>#10yearsATP1A3

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}